These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7784092)

  • 61. [The molecular genetics of multiple endocrine neoplasia type 2A and 2B].
    Yoshimoto K
    Nihon Rinsho; 1994 Apr; 52(4):1081-6. PubMed ID: 7910861
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.
    Pasini A; Geneste O; Legrand P; Schlumberger M; Rossel M; Fournier L; Rudkin BB; Schuffenecker I; Lenoir GM; Billaud M
    Oncogene; 1997 Jul; 15(4):393-402. PubMed ID: 9242375
    [TBL] [Abstract][Full Text] [Related]  

  • 63. RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.
    Neocleous V; Skordis N; Portides G; Efstathiou E; Costi C; Ioannou N; Pantzaris M; Anastasiadou V; Deltas C; Phylactou LA
    J Endocrinol Invest; 2011 Nov; 34(10):764-9. PubMed ID: 21422799
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Korean family of familial medullary thyroid cancer with Cys618Ser RET germline mutation.
    Jung J; Uchino S; Lee Y; Park H
    J Korean Med Sci; 2010 Feb; 25(2):226-9. PubMed ID: 20119574
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A new inherited RET proto-oncogene mutation associated with familial medullary thyroid carcinoma and polymorphisms in adjacent regions].
    Kalinin VN; Amosenko FA; Puskas C; Frilling A; Broelsch CE
    Genetika; 1998 Aug; 34(8):1157-9. PubMed ID: 9777362
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Frequent association between MEN 2A and cutaneous lichen amyloidosis.
    Verga U; Fugazzola L; Cambiaghi S; Pritelli C; Alessi E; Cortelazzi D; Gangi E; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):156-61. PubMed ID: 12864791
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An extended family with familial medullary thyroid carcinoma and Hirschsprung's disease.
    Igarashi T; Okamura R; Jikuzono T; Uchino S; Sugitani I; Shimizu K
    J Nippon Med Sch; 2014; 81(2):64-9. PubMed ID: 24805091
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Familial medullary thyroid cancer and prominent corneal nerves: clinical and genetic analysis.
    Kane LA; Tsai MS; Gharib H; Khosla S; Robertson DM; Schaid DJ; Honchel R; Thibodeau SN
    J Clin Endocrinol Metab; 1995 Jan; 80(1):289-93. PubMed ID: 7829628
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mutation of RET proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
    Migita M; Hiromatsu Y; Sato M; Yang D; Kameo J; Jimi A; Nonaka K
    Endocr J; 1997 Aug; 44(4):559-65. PubMed ID: 9447290
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens.
    Komminoth P; Muletta-Feurer S; Saremaslani P; Kunz EK; Matias-Guiu X; Hiort O; Schroder S; Seelentag WK; Roth J; Heitz PU
    Endocr Pathol; 1995; 6(4):267-278. PubMed ID: 12114809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiple endocrine neoplasias.
    Phay JE; Moley JF; Lairmore TC
    Semin Surg Oncol; 2000 Jun; 18(4):324-32. PubMed ID: 10805954
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Medullary carcinomas of the thyroid: a monoclonal origin.
    Marques AR; Catarino AL; Moniz S; Cavaco B; Roque L; Sobrinho L; Leite V
    Thyroid; 2001 Dec; 11(12):1109-13. PubMed ID: 12186497
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sporadic endocrine tumours and their relationship to the hereditary endocrine neoplasia syndromes.
    Koper JW; Lamberts SW
    Eur J Clin Invest; 2000 Jun; 30(6):493-500. PubMed ID: 10849017
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multiple endocrine neoplasia (MEN)-associated tumours.
    Bordi C
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S31-4. PubMed ID: 15077909
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A.
    Gagel RF; Cote GJ; Martins Bugalho MJ; Boyd AE; Cummings T; Goepfert H; Evans DB; Cangir A; Khorana S; Schultz PN
    J Intern Med; 1995 Oct; 238(4):333-41. PubMed ID: 7595169
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Familial MTC with
    Saltiki K; Anagnostou E; Simeakis G; Kouki S; Angelopoulou A; Sarika L; Papathoma A; Alevizaki M
    Endocr Connect; 2017 Nov; 6(8):676-684. PubMed ID: 28951487
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of a polymorphism in exon 11 of the RET protooncogene.
    Bugalho MJ; Cote GJ; Khorana S; Schultz PN; Gagel RF
    Hum Mol Genet; 1994 Dec; 3(12):2263. PubMed ID: 7881435
    [No Abstract]   [Full Text] [Related]  

  • 78. Multiple endocrine neoplasia--syndromes of the twentieth century.
    Thakker RV
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2617-20. PubMed ID: 9709920
    [No Abstract]   [Full Text] [Related]  

  • 79. [Screening of families of patients with medullary cancer of the thyroid].
    Szántó J; Vincze B; Revitzky AL
    Orv Hetil; 1982 Jul; 123(28):1737-40. PubMed ID: 7122102
    [No Abstract]   [Full Text] [Related]  

  • 80. A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma.
    Hofstra RM; Fattoruso O; Quadro L; Wu Y; Libroia A; Verga U; Colantuoni V; Buys CH
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4176-8. PubMed ID: 9398735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.